Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference
Apellis Pharmaceuticals (Nasdaq: APLS) will present at the Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025 at 2:40 p.m. ET. The company said a live webcast will be posted on the Events and Presentations page of its Investors and Media website. A replay of the webcast will be available for approximately 90 days after the event.
Apellis Pharmaceuticals (Nasdaq: APLS) parteciperà al Stifel 2025 Healthcare Conference il mercoledì 12 novembre 2025 alle 14:40 ET. L'azienda ha dichiarato che una trasmissione in diretta sarà pubblicata sulla pagina Events and Presentations del suo sito web per Investitori e Media. Una replica della trasmissione sarà disponibile per circa 90 giorni dopo l'evento.
Apellis Pharmaceuticals (Nasdaq: APLS) participará en la Stifel 2025 Healthcare Conference el miércoles 12 de noviembre de 2025 a las 2:40 p.m. ET. La empresa dijo que se publicará una transmisión en vivo en la página Events and Presentations de su sitio web de Inversores y Medios. Una reproducción de la transmisión estará disponible durante aproximadamente 90 días después del evento.
Apellis Pharmaceuticals (나스닥: APLS)는 Stifel 2025 헬스케어 컨퍼런스에 2025년 11월 12일 수요일 동부 표준시 ET 14:40에 발표합니다. 회사는 라이브 웹캐스트가 투자자 및 언론 웹사이트의 Events and Presentations 페이지에 게시될 예정이라고 말했습니다. 웹캐스트의 재생은 행사 후 대략 90일 동안 이용 가능할 것입니다.
Apellis Pharmaceuticals (Nasdaq : APLS) participera au Stifel 2025 Healthcare Conference le mercredi 12 novembre 2025 à 14h40 ET. L'entreprise a déclaré qu'une webdiffusion en direct sera publiée sur la page Events and Presentations de son site Internet pour investisseurs et médias. Une rediffusion de la webdiffusion sera disponible pendant environ 90 jours après l'événement.
Apellis Pharmaceuticals (Nasdaq: APLS) wird am Stifel 2025 Healthcare Conference am Mittwoch, dem 12. November 2025 um 14:40 Uhr ET teilnehmen. Das Unternehmen erklärte, dass ein Live-Webcast auf der Seite Events and Presentations seiner Website für Investoren und Medien veröffentlicht wird. Eine Wiederholung des Webcasts wird ca. 90 Tage nach der Veranstaltung verfügbar sein.
شركة Apellis للصناعات الدوائية (ناسداك: APLS) ستقدم في مؤتمر Stifel للرعاية الصحية 2025 يوم الأربعاء 12 نوفمبر 2025 الساعة 2:40 مساءً بتوقيت شرق الولايات المتحدة. قالت الشركة إنه سيتم نشر بث مباشر على صفحة Events and Presentations ضمن موقعها الإلكتروني للمستثمرين ووسائل الإعلام. سيكون بإمكان المستمعين إعادة تشغيل البث لمدة حوالي 90 يوماً بعد الحدث.
- None.
- None.
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025 at 2:40 p.m. ET.
The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.
About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X.
Investor Contact:
Eva Stroynowski
ir@apellis.com
617.938.6229